Atlas Trials

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

Clinical trial NCT00562783 · COMPLETED

Trial details

NCT number
NCT00562783
Sponsor
Hospital Authority, Hong Kong
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis BHepatitis CLiver Cirrhosis
Start date
2005-01-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.